DR AGARWALS HEALTH CARE
|
|
| BOM : 544350 NSE : AGARWALEYE | |
| LT :
Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : Average |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Jun 05,2026 |
|
Price(EOD): ₹ 459.35
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
| MCap: ₹ 14,561.40 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| DR AGARWALS HEALTH CARE | -4.4% | 0.3% | 37.3% |
| APOLLO HOSPITALS ENTERPRISE | 2.5% | 7.1% | 19.9% |
| MAX HEALTHCARE INSTITUTE | 4.1% | -3.8% | -14.1% |
| FORTIS HEALTHCARE | 4.4% | 1.2% | 33% |
| ASTER DM HEALTHCARE | 4.5% | 3.1% | 32% |
| NARAYANA HRUDAYALAYA | 3.5% | 7.1% | 11.5% |
| GLOBAL HEALTH | 6.1% | 4.9% | 3.6% |
| KRISHNA INSTITUTE OF MEDICAL SCIENCES | 4.8% | 12.7% | 11.8% |
| DR LAL PATHLABS | -2.7% | -3.2% | 11.9% |
FUNDAMENTAL ANALYSIS OF DR AGARWALS HEALTH CARE
[ Q(TTM): Mar2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF DR AGARWALS HEALTH CARE
[As on : Jun 05,2026
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
86.6
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 168.14 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] 7.19
P/B Calculated based on Book Value of Rs 2,025.46 Cr
[Latest Year - Mar2026 - Consolidated Results ] 7
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 2,080.08 Cr
[Latest Qtr - Mar2026 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
2767% 2318% -27% |
SHARE PRICE MOMENTUM OF DR AGARWALS HEALTH CARE
DR AGARWALS HEALTH CARE vs SENSEX
DEBT OF DR AGARWALS HEALTH CARE
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.08 0.27 0.55 0.3 |
0.13 0.29 0.57 0.33 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF DR AGARWALS HEALTH CARE
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2026 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF DR AGARWALS HEALTH CARE
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
6.46% 12.05% 18.31% 14.51% |
22.57% 23.27% 30.93% 17.41% |
| QtrlyTrend |
8 | |
| Latest Qtr: Mar2026 | ||
| Quarterly Result Analysis → | ||
DR AGARWALS HEALTH CARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE HOSPITALS | 2.4% | 4.2% | NA |
| BSE 250 SMALLCAP INDEX | 0.2% | 0.6% | 0.7% |
| BSE HEALTHCARE | 0.2% | 3.5% | 9.8% |
| BSE 1000 | -0.7% | -1.3% | -1.9% |
| BSE 400 MIDSMALLCAP INDEX | -0.8% | 0.5% | 2.3% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY MICROCAP 250 | 1.1% | 2.6% | 2% |
| NIFTY SMALLCAP 500 | 0.5% | NA | NA |
| NIFTY 500 EQUAL WEIGHT | -0.2% | -0.1% | 1.3% |
| NIFTY MIDSMALLCAP400 50:50 | -0.5% | NA | NA |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -0.6% | -0.4% | 1% |
You may also like the below Video Courses
FAQ about DR AGARWALS HEALTH CARE
Is DR AGARWALS HEALTH CARE good for long term investment?
As on Jun 05,2026, the Fundamentals of DR AGARWALS HEALTH CARE look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of DR AGARWALS HEALTH CARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is DR AGARWALS HEALTH CARE UnderValued or OverValued?
As on Jun 05,2026, DR AGARWALS HEALTH CARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of DR AGARWALS HEALTH CARE ?
As on Jun 05,2026, the Intrinsic Value of DR AGARWALS HEALTH CARE is Rs. 19.00 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 16.02
Fair Value [Median EV / Sales Model] : Rs. 19.00
Fair Value [Median Price / Sales Model] : Rs. 625.25
Estimated Median Fair Value of DR AGARWALS HEALTH CARE : Rs. 19.00
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
